Catalyst Pharmaceuticals

Catalyst Pharmaceuticals: Catalyst Pharmaceuticals is a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare diseases. With exceptional patient focus, Catalyst is committed to developing a robust pipeline of cutting-edge, best-in-class medicines for rare diseases. Catalyst's New Drug Application for FIRDAPSEĀ® (amifampridine) Tablets 10 mg for the treatment of adults with Lambert-Eaton myasthenic syndrome ("LEMS") was approved in 2018 by the U.S. Food & Drug Administration ("FDA") and FIRDAPSE is commercially available in the United States as a treatment for adults and children ages six to seventeen with LEMS. Further, Canada's national healthcare regulatory agency, Health Canada, has approved the use of FIRDAPSE for the treatment of adult patients in Canada with LEMS.
Based in...
US - South Atlantic
Clinical Stage
Phase III, Phase l or ll
Disease Space
Rare Disease
Public, USA
Market Cap
1B +
Therapeutic Modalities
Small Molecule
355 Alhambra Circle
Suite 801
Coral Gables, FL 33134
United States

Company Participants at Solebury Trout 1x1 Management Access Event 2022

  • Jeff Del Carmen, CCO
  • Mary Coleman, Vice President, Investor Relations
  • Patrick J McEnany, Chairman/President/CEO/Co-Founder
  • Steven Miller, Chief Operating Officer & Chief Scientific Officer

Top 10 Holders of Catalyst Pharmaceuticals, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
BlackRock Fund Advisors 11.45 11,918,319 189.74 13F 12/31/22
State Street Corp. 7.57 7,873,314 125.34 13F 12/31/22
Vanguard Group, Inc. (Subfiler) 6.27 6,522,012 103.83 13F 12/31/22
Deerfield Management Co. LP 5.65 5,884,448 93.68 13F 12/31/22
The Vanguard Group, Inc. 5.48 5,707,009 90.86 Funds 2/28/23
BlackRock Institutional Trust Co. NA 2.37 2,469,183 39.31 13F 12/31/22
Millennium Management LLC 2.22 2,313,666 36.83 13F 12/31/22
Dimensional Fund Advisors LP 2.22 2,308,705 36.75 13F 12/31/22
Two Sigma Investments LP 1.85 1,925,090 30.65 13F 12/31/22
Two Sigma Advisers LP 1.74 1,810,992 28.83 13F 12/31/22
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2023 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.